Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Caitlin E. Cox

May 06, 2025

News Daily News

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Michael O'Riordan

March 06, 2025

News Daily News

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Todd Neale

November 13, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News ESC 2023

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Caitlin E. Cox

August 30, 2023

News Conference News ACC 2023

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Shelley Wood

March 04, 2023

News Daily News

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Michael O'Riordan

February 16, 2023

News Daily News

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

L.A. McKeown

February 13, 2023

News Daily News

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Michael O'Riordan

November 17, 2022

News Conference News EuroPCR 2022

Registry Data Hint at MACE Benefit With Renal Denervation

Michael O'Riordan

May 17, 2022

News Daily News

Discharge Safe as Early as a Day After Primary PCI for STEMI

L.A. McKeown

December 15, 2021

News Daily News

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

L.A. McKeown

November 01, 2021

News Conference News SCAI 2021

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

Michael O'Riordan

May 06, 2021

News Daily News

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Yael L. Maxwell

September 14, 2020

News Daily News

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

Michael O'Riordan

December 03, 2019

News Conference News ESC 2019

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Shelley Wood

August 31, 2019

News Daily News

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Michael O'Riordan

August 26, 2019

News Daily News

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Michael O'Riordan

April 10, 2019

Advertisement

AHA/ACC Issue New Performance, Quality Measures for Chronic Coronary Disease

Less Plaque Progression With CAC-Guided Primary Prevention: CAUGHT-CAD

Many Patients Quit Taking GLP-1 Drugs: Understanding Why Is Key

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

New ESC Guidelines for CVD in Patients With Diabetes Cover Wide Ground

Stable CAD Plaque Morphology Improved by PCSK9 Inhibitors: YELLOW III

Longer-Term ASCVD Risk Assessment Best for Younger Patients

Maternal CV Risk After Adverse Pregnancy Outcome Can Last Over 40 Years

How Lp(a) Levels Compare With LDL-C in FH: Some Surprises

Registry Data Hint at MACE Benefit With Renal Denervation

Discharge Safe as Early as a Day After Primary PCI for STEMI

CVD Risk ‘Underappreciated’ After Adverse Pregnancy Outcomes

ISCHEMIA: PCI/CABG Has Early Hospitalization ‘Tax’ but Equals Meds Later

LDL Cholesterol Control Post-PCI Is Low and Linked to Worse Outcomes

Non-HDL Cholesterol Strongly Tied to Lifetime CVD Risk

New ‘Chronic Coronary Syndrome’ Guidelines Stress There’s Nothing Stable About CAD

Highest Risk, Biggest Benefit in ACS Patients Treated With Alirocumab: ODYSSEY OUTCOMES

Younger Type 2 Diabetes Patients Face Higher Mortality and CVD Risks

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content